NASDAQ: AKBA       Akebia Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
3.53   +0.19 (5.69%)  3.39 - 3.88  1,061,844


Avg Volume (4 weeks):1,115,000
4 Weeks Range:2.99 - 4.25
4 Weeks Price Volatility (%):
52 Weeks Range:2.99 - 10.45
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

  Be the first to like this.


1715  3821  538  2903 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACB 3.126+0.486 
 AABA 19.630.00 
 AMD 39.23-1.75 
 UBER 29.325+1.295 
 CHK 0.5710.00 
 GGB 3.77+0.17 
 SCHW 48.17+3.42 
 M 14.75-0.27 
 ONTX 0.167-0.135 
Partners & Brokers